{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:01:53Z","timestamp":1788822113853,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1124\/dmd.115.066316","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T02:24:36Z","timestamp":1443061476000},"page":"1938-1945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dose of Phenobarbital and Age of Treatment at Early Life are Two Key Factors for the Persistent Induction of Cytochrome P450 Enzymes in Adult Mouse Liver"],"prefix":"10.1016","volume":"43","author":[{"given":"Yun-Chen","family":"Tien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bo","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.066316_bib1","first-page":"E439","article-title":"Neonatal phenobarbital-induced defects in age- and sex-specific growth hormone profiles regulating monooxygenases","volume":"268","author":"Agrawal","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.115.066316_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3565(25)21214-9","article-title":"Imprinted overinduction of hepatic CYP2B1 and 2B2 in adult rats neonatally exposed to phenobarbital","volume":"279","author":"Agrawal","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.066316_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0026-895X(25)08739-5","article-title":"Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose","volume":"49","author":"Agrawal","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0022-3565(24)39329-2","article-title":"Latent overexpression of hepatic CYP2C7 in adult male and female rats neonatally exposed to phenobarbital: a developmental profile of gender-dependent P450s","volume":"293","author":"Agrawal","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.066316_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1096\/fj.04-2550fje","article-title":"Neonatal phenobarbital imprints overexpression of cytochromes P450 with associated increase in tumorigenesis and reduced life span","volume":"19","author":"Agrawal","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.066316_bib6","doi-asserted-by":"crossref","first-page":"G1578","DOI":"10.1152\/ajpgi.00359.2006","article-title":"beta-Catenin is critical for early postnatal liver growth","volume":"292","author":"Apte","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.115.066316_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","article-title":"Neonatal seizures: multicenter variability in current treatment practices","volume":"37","author":"Bartha","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1124\/dmd.115.066316_bib8","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1096\/fj.14-269043","article-title":"Translating dosages from animal models to human clinical trials--revisiting body surface area scaling","volume":"29","author":"Blanchard","year":"2015","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.066316_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1440-1754.2005.00638.x","article-title":"Drug treatment of neonatal seizures by neonatologists and paediatric neurologists","volume":"41","author":"Carmo","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1124\/dmd.115.066316_bib10","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1124\/dmd.108.022970","article-title":"Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro","volume":"36","author":"Chang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.066316_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.25766","article-title":"Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver","volume":"56","author":"Chen","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/dmd.115.066316_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.103.058818","article-title":"Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor","volume":"308","author":"Chen","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.066316_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: ontogeny and drug disposition","volume":"37","author":"de Wildt","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.115.066316_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pharmtox.44.101802.121453","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"44","author":"Gandhi","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.115.066316_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cellsig.2005.07.007","article-title":"Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide","volume":"18","author":"Gerbal-Chaloin","year":"2006","journal-title":"Cell Signal"},{"key":"10.1124\/dmd.115.066316_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00008571-199906000-00004","article-title":"Human CYP2B6: expression, inducibility and catalytic activities","volume":"9","author":"Gervot","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.115.066316_bib17","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0009-9236(03)00187-5","article-title":"The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity","volume":"74","author":"Gorski","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.066316_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00280-004-0988-6","article-title":"P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing","volume":"56","author":"Gustafson","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/pr.55.4.2","article-title":"Induction of drug metabolism: the role of nuclear receptors","volume":"55","author":"Handschin","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.115.066316_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/dmd.108.023812","article-title":"Three patterns of cytochrome P450 gene expression during liver maturation in mice","volume":"37","author":"Hart","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.066316_bib23","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1128\/MCB.18.10.5652","article-title":"The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene","volume":"18","author":"Honkakoski","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.115.066316_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0167-4889(02)00323-3","article-title":"Cytokine regulation of liver development","volume":"1592","author":"Kinoshita","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.115.066316_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1101\/sqb.2011.76.010710","article-title":"Roles of FGF19 in liver metabolism","volume":"76","author":"Kir","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1124\/dmd.115.066316_bib26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/jpet.103.060137","article-title":"Developmental expression of human hepatic CYP2C9 and CYP2C19","volume":"308","author":"Koukouritaki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.066316_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1124\/dmd.110.034223","article-title":"Expression and functional analysis of hepatic cytochromes P450, nuclear receptors, and membrane transporters in 10- and 25-week-old db\/db mice","volume":"38","author":"Lam","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.066316_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/WNL.45.4.724","article-title":"A population-based study of neonatal seizures in Fayette County, Kentucky","volume":"45","author":"Lanska","year":"1995","journal-title":"Neurology"},{"key":"10.1124\/dmd.115.066316_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/archdischild-2011-300538","article-title":"Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures","volume":"97","author":"Lee","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1124\/dmd.115.066316_bib30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/mol.108.052993","article-title":"Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation","volume":"75","author":"Li","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.pharmtox.41.1.535","article-title":"Interindividual variability in inhibition and induction of cytochrome P450 enzymes","volume":"41","author":"Lin","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.115.066316_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1203\/PDR.0b013e318165b8af","article-title":"Dexamethasone exposure of neonatal rats modulates biliary lipid secretion and hepatic expression of genes controlling bile acid metabolism in adulthood without interfering with primary bile acid kinetics","volume":"63","author":"Liu","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1124\/dmd.115.066316_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/dmd.106.012831","article-title":"The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A","volume":"35","author":"Ma","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.066316_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tig.2012.06.008","article-title":"Relating human genetic variation to variation in drug responses","volume":"28","author":"Madian","year":"2012","journal-title":"Trends Genet"},{"key":"10.1124\/dmd.115.066316_bib35","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.115.066316_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.107.039354","article-title":"Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter","volume":"73","author":"Onica","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.066316_bib37","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1124\/dmd.112.045088","article-title":"RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development","volume":"40","author":"Peng","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.066316_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.066316_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002040050037","article-title":"Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs","volume":"68","author":"Rekka","year":"1994","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.115.066316_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfr240","article-title":"Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice","volume":"124","author":"Renaud","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.115.066316_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(99)70374-4","article-title":"The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study","volume":"134","author":"Ronen","year":"1999","journal-title":"J Pediatr"},{"key":"10.1124\/dmd.115.066316_bib42","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1074\/jbc.274.10.6043","article-title":"The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene","volume":"274","author":"Sueyoshi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.115.066316_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2710.1999.00246.x","article-title":"Gender-related differences in pharmacokinetics and their clinical significance","volume":"24","author":"Tanaka","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/dmd.115.066316_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.siny.2013.01.001","article-title":"Treatment of neonatal seizures","volume":"18","author":"van Rooij","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1124\/dmd.115.066316_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1124\/dmd.115.066316_bib46","doi-asserted-by":"crossref","first-page":"29295","DOI":"10.1074\/jbc.M400580200","article-title":"Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624102449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.066316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:25:42Z","timestamp":1739906742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624102449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0090955624102449"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.066316","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose of Phenobarbital and Age of Treatment at Early Life are Two Key Factors for the Persistent Induction of Cytochrome P450 Enzymes in Adult Mouse Liver","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.066316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}